002390 信邦制药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.5904.2053.3424.7303.560
总资产报酬率 ROA (%)1.9473.0172.3102.8291.728
投入资产回报率 ROIC (%)2.2723.4972.6723.2392.096

边际利润分析
销售毛利率 (%)18.42519.01619.16520.89821.419
营业利润率 (%)5.8545.9594.9816.9774.917
息税前利润/营业总收入 (%)6.0786.5595.5497.8545.991
净利润/营业总收入 (%)5.0985.4764.2245.7783.773

收益指标分析
经营活动净收益/利润总额(%)109.166108.803106.719111.147134.352
价值变动净收益/利润总额(%)0.4922.37311.9420.931-6.345
营业外收支净额/利润总额(%)-1.1252.775-0.935-7.215-7.458

偿债能力分析
流动比率 (X)2.9242.6292.1612.0241.363
速动比率 (X)2.3992.1431.7771.6851.174
资产负债率 (%)20.22922.74627.86129.08146.508
带息债务/全部投入资本 (%)10.11413.26919.18019.869--
股东权益/带息债务 (%)883.459649.425418.799400.538137.099
股东权益/负债合计 (%)377.022325.857249.518236.408109.450
利息保障倍数 (X)21.02515.2699.0405.8314.232

营运能力分析
应收账款周转天数 (天)165.350161.257164.537147.5860.000
存货周转天数 (天)69.77369.95669.02662.5540.000